Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Receivables (2018 - 2026)

Health Catalyst filings provide 9 years of Receivables readings, the most recent being $65.6 million for Q1 2026.

  • On a quarterly basis, Receivables fell 8.5% to $65.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $65.6 million, a 8.5% decrease, with the full-year FY2025 number at $69.2 million, changed 0.36% from a year prior.
  • Receivables hit $65.6 million in Q1 2026 for Health Catalyst, down from $69.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $77.1 million in Q2 2025 to a low of $43.3 million in Q1 2022.
  • Median Receivables over the past 5 years was $61.4 million (2024), compared with a mean of $60.1 million.
  • Biggest five-year swings in Receivables: skyrocketed 46.7% in 2023 and later dropped 9.74% in 2024.
  • Health Catalyst's Receivables stood at $48.9 million in 2022, then soared by 32.99% to $65.0 million in 2023, then rose by 6.14% to $69.0 million in 2024, then grew by 0.36% to $69.2 million in 2025, then fell by 5.17% to $65.6 million in 2026.
  • The last three reported values for Receivables were $65.6 million (Q1 2026), $69.2 million (Q4 2025), and $68.6 million (Q3 2025) per Business Quant data.